Organisation paid for research Program year 2020 Source: CMS Open Payments

Amer Health Network

Neither a doctor nor a teaching hospital

Research payments

$320,379

31 payments

Through program year 2020, Amer Health Network is reported as receiving $320,379 in research payments, across 31 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$169,784	10
2019	Research	$150,595	21

Breakdown

Who paid Research payments · program years 2019–2020

AstraZeneca Pharmaceuticals LP $218,187 21 payments
AstraZeneca UK Limited $102,192 10 payments

Studies the money was for Research payments · program years 2019–2020

A Long Term Outcomes Study to Assess STatin Residual Risk Reduction with EpaNova in HiGh Cardiovascular Risk PatienTs with Hypertriglyceridemia $241,007 24 payments
Dapagliflozin Effect on Cardiovascular Events A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes $42,603 3 payments
A Phase 3b, Multicenter, Open-Label, Single-Arm Study of Acalabrutinib (ACP-196) in Subjects with Chronic Lymphocytic Leukemia $25,171 2 payments
A Multinational Randomised Double Blind Placebo Controlled Trial to Evaluate the Effect of Ticagrelor 90 mg twice daily on the Incidence of Cardiovascular Death Myocardial Infarction or Stroke in Patients with Type 2 Diabetes $11,597 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.